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Abstract The lytic transglycosylases of Escherichia eoli are 
involved in peptidoglycan metabolism and resemble the lysozymes 
not only in activity, but in the case of the 70 kDa soluble lytic 
transglycosylase (Sit70), also structurally. Here we report the 
cloning of the gene that encodes the 35 kDa soluble lyric transgly- 
cosylase (Sit35) of E. coil Based on the sequence of the full- 
length gene, Slt3$ is very likely to be a proteolytically truncated 
form of a slightly larger protein. The homology between Sit35 and 
Sit70, albeit poor, Indicates that the active site architecture of 
both proteins may be alike. Using the I"-7 promoter system, Slt35 
was overproduced in large quantities and purified to homogeneity 
for crystallographic purposes. 
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1. Introduction 
The peptidoglycan layer of bacteria is a polymeric macro- 
molecule that is composed of glycan strands of alternating 
N-acetylglucosamine and N-acetylmuramic a id, cross-linked 
by short peptide bridges (for a recent review see [1]). This 
macromolecule encloses the bacterial cell, thereby serving as a 
casing that protects the cell from mechanical stress and allows 
it to maintain a high internal osmotic pressure. Although the 
protective nature ui' the peptidoglycan layer implies rigidity, 
flexibility is required for the cell to be able to grow and divide. 
These paradoxical characteristics are reflected in a complex 
metabolic machinery that involves the well-balanced action of 
an array of synthesizing and hydrolyzing activities. Of the dif- 
ferent enzymes involved, most attention has been given over the 
years to the penicillin-binding proteins, as it is this class of 
enzymes that is the direct target of,8-1actam antibiotics. The 
emergence of resistance against his extensively used class of 
antibiotics has, however, resulted in a quest for new anti- 
bacterial targets and the non-penicillin sensitive nzymes in- 
volved in the peptidoglycan metabolism can be considered po- 
tential candidates. Among these are the iytic transglycosylases, 
a class of peptidoglycan hydrolyzing enzymes that was origi- 
nally identified in Escherichia coil Based on the presence of 
genes homologous to the E. coil sit gene in Enterobacter cloacae 
and Salmonella typhimurium [2], and the release of the specific 
products of these enzymes by Bordetella pertussis [3] and Neis- 
sd'ta gonorrhoeae [4], members of this class are expected to be 
present in a broad range of Gram-negative bacteria. The activ- 
ity of the lyric transglycosylases is the cleavage of the fl-glyco- 
*Corresponding author. Fax: (41) (61) 688-2729. 
sidle bond between the N-acetylglucosamine and N-acetylmu- 
ramie acid residue, an activity resembling that of the lysozymes, 
but in addition these enzymes introduce an internal 1,6-anhy- 
dro bond in the muramic acid residue of the monomeric 
muropeptide product [5]. Of the E. coli transglycosylases, the 
70 kDa solub|~ protein (Sit70) has been the most extensively 
studied, and the three-dimensional structure of this enzyme has 
recently become available [6]. The activity of Sit70, however, 
does not seem to be essential for growth of E. coli under labo- 
ratory conditions and the only known inhibitor of this enzyme, 
bulgecin, is not an antibiotic in its own right but only shows 
synergistic antibacterial ctivity in combination with/~-lactam 
compounds [7]. The reason for this may be the presence of at 
least wo more transglycosylases in E. coii that are not inhibited 
by bulgecin, and may substitute for the activity of Sit70 [8-10]. 
From an antibacterial point of view, the main object will there- 
fore be to tackle this class of enzymes as a whole, and for this 
purpose more functional and structural information is needed 
about the two smaller enzymes. 
This report describes the cloning of the gene coding fc," one 
of those, the 35 kDa soluble lyric transglycosylase (Sit35). After 
confirmation of the transglycosylase activity of the gene prod- 
uct, a stable form of the protein was purified for further crystal- 
lographic studies. 
2. Materials and methods 
2.1. Molecular clon#ag methods 
General DNA manipulations and cloning procedures were per- 
formed according to described protocols [i !]. Plasmid DNA was pre- 
pared using Qiagen (Hilden, Germany) puritication systems. Dideoxy 
sequencing was performed using the Sequenase v rsion 2.0 kit (Amer- 
sham, Buckinghamshire, UK), following the manufacturers instruc- 
tions. The Chameleon system (Stratagene, La Jolla, CA, USA) was 
used to introduce site-directed mutations. PCR reactions were per- 
formed with AmpliTaq DNA.polymerase and reagents from Perkin 
Elmer (Norwalk, CT, USA) with the following cycling protocol: melt- 
ing at 94"C for ! rain, annealing at 45"C for ! rain, and extension at 
72"C for 1 rain for a total of 30 cycles. 
2.2. Cloning and sequencing ofthe Sit35 encoding ene and surround#lg 
region 
Two degenerate oligonucleotides (A-II: 5'-CAYAAYGTNATGC- 
ARATGGG-Y; AI2: 5'-RTCRATRAAYTGYTGNGC-3'), the se- 
quences of which were based on the N-terminal amino acid sequence 
of S1t35 [8], were used to amplify a 63 base pair fragment. The ampli- 
fied fragment was sequenced, reamplified to incorporate [0tnP]dATP, 
and was used as a probe in a Southern hybridization procedure on Kpnl 
and Pstl digested genomic DNA of E. ~'oli strain 122-1, which has a 
deletion for the gene coding for Sit70 [12]. Two subgenomic libraries 
were constructed by cloning of genomic DNA fragments of the size 
range corresponding to that of the hybridization signal into pUCI8 
(Pharmacia, Upsalla, Sweden). After transformation i to super compe- 
tent XLl-blue (Stratagene, La Jolla, CA, USA), the transformant col- 
onies were screened using the same 63-mer as a probe. One positive 
clone from each library was selected lbr further analysis, and the gene 
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coding for Sit35 plus the surrounding region was sequenced byprimer 
walking. 
2.3. Overproduction a d purification 
Using site.directed mutagenesis, an NcoI site was constructed, chang- 
ing the codon for Leu-40 into an ATG start codon (primer A62: 5"- 
GC~CAACCATGGAGCCGCCAGACCGGT-3'). For selec- 
tion of the mutant strand, an oligonucleotide mutating the unique Bsal 
site in the ampicillin resistance g ne ofpUCl8 was used (primer A44: 
5'-GGTGAGCGTGGTTCTCGCGGTAT-Y). The 1.9 kb NcoI frag- 
ment of the resulting plasmid pAD115 was cloned into the Ncol site of 
the vector pE'I21d+ (Novagen, Madison, WI, USA), thereby bringing 
the expression fS!t35 under the control of the T7 promoter [13]. The 
expression construct pADI21 was transformed into host BL21(DE3) 
and expr~sion was induced by the addition of I mM IPTG. For the 
large scale purification, 60 g of induced cells (wet weight) were resus- 
pended in 10 mM Tris-maleate-NaOH buffer, pH 7.3, disrupted by 
passage through an Aminco French pressure cell at 15,000 psi, and the 
soluble fraction was obtained by centrifugation at 100,000 ×g for one 
hour, The soluble fraction was loaded on a 80-ml SP-sepharosc fast 
flow column (Pharmacia, Uppsala, Sweden) and bound protein was 
eluted by applying a linear gradient of 0-1 M NaCI in 10 mM Tris- 
maleate-NaOH. Fractions containing S!t35 (eluting at 0.2 M NaCI) 
were pooled, dialyzed against 10 mM phosphate buffer, pH 6.8, and 
loaded in three consecutive runs on a 20 ml Bio-scale hydroxylapatite 
column (Bio.Rad Laboratories, Hercules, CA, USA). Using a linear 
gradient from 10 mM to 500 mM phosphate, bound proteins were 
resolved and only the peak fractions containing Sit35 in its purest form 
(eluting at 150 mM phosphate) were pooled, yielding atotal of 310 mg 
of Sit35. 
2,4. Peptidoglycan hydrolase assay, product analysis and :ymography 
Peptidoglycan hydrolase activity was determined bymeasuring solu- 
bilization of radiolabeled peptidogiycan polymer following apublished 
procedure [14]. 
HPLC analysis of the produced muropeptides was performed essen- 
tially as described [8]: isolated peptidoglycan was degraded with puri- 
fied Sit35 and the released muropeptides were separated by HPLC, 
using a linear gradient from 0.05% trifluoroacetic a id to 0.035~ tri- 
fluoroacetic a id containing 20% acetonitrile over 60 mitt. The retention 
times of the released muropeptides were compared with those of puri- 
fied monomeric 1,6-anhydro.muropeptides, of which the structure had 
been confirmed by tandem electron-spray mass pectroscopy. 
Zymogram analysis of crude xtracts and purified protein was car- 
ried out essentially asdescribed [15], using 10% PAA gels, loaded with 
0.03% purified £ coil peptidogiycan. 
3. Results and dbeusdon 
Based on the N-terminal sequence information, two overlap- 
ping clones carrying the full-length gene coding for the 35 kDa 
soluble lytic transgly~sylase w re isolated, Sequence compari- 
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Fig. 1. Mapping position of the Slt35-encodingmltB gene. The 60.8 min 
region of the E. coil chromosomal map between alaS and gutA is 
depicted. The position and direction of transcription f the genes in this 
region is indicated by the open arrows, whereas the solid arrow repre- 
sents the 4.8 kb/~nI fragment that was cloned and from which the 
sequence ofthe mltB gene was determined. 
son revealed that the first 276 base pairs of the coding region 
were present in the GenBank database, as being part of the 
upstream region of the gut operon, although the authors did not 
identify the open reading frame [16]. This information allowed 
mapping of the gene at 60.8 min on the E. coli chromosomal 
map, between the gut operon and the recA gene [17] (Fig. 1). 
During preparation of this manuscript, a sequence was submit. 
ted to GenBank (accession umber U18785), which covers the 
same region. The gene coding for S1t35 is called mltB by these 
authors and to avoid confusion, we will use this gene name in 
the future. 
Primary sequence analysis revealed that the gene product is 
a very positively charged protein (a calculated pl of 9.4 for the 
precursor protein). This positive charge may ensure an optimal 
interaction with the peptidoglycan substrate, which is highly 
.negatively charged. 
The spacing between the published N-terminal sequence and 
the first possible ATG start codon upstream isunusually large. 
Although this possible start codon is followed by a stretch of 
sequence displaying the characteristics of a consensus ignal 
sequence, i,e. a short stretch of sequence containing positively 
charged residues followed by a longer hydrophobic stretch [18], 
no consensus ignal peptidase cleavage site at the start of the 
published N-terminal sequence could be detected. Rather, di- 
rectly following the hydrophobic stretch, a possible cleavage 
site for the lipoprotein signal peptidase II is present [19]. The 
cysteine of this cleavage site is separated from the first residue 
of the published N-terminal sequence by 20 amino acid residues 
(Fig. 2). It therefore seems likely that the protein encoded by 
the mltB gene is a lipoprotein and that the lipid anchor and the 
active domain are linked by a proteolysis-prone spacer. This 
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Fig, 2, Amino acid sequence of the mltB gene product and alignment with Sit70. The putative signal peptidase cleavage site is indicated by an arrow. 
The arrow head marks the N-terminus of the overproduced protein, Of the alignment with SItTO, only the region containing the two conserved motifs 
(underlined) is shown (see text for further details). Identical residues an= indicated by bars. 
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Fig. 3. Purification of overexpressed S1t35. (A) Analysis of cell homoge- 
nares and pooled fractions by SDS-polyacrylamide gel lectrophoresis. 
Lanes 1 and 2 = total cellular protein (50 ,ug) of strain BL21(DE3) 
containing plasmid pADI21 before and after induction, respectively; 
lanes 3 and 4 = 10/tg of protein from pooled fractions after elution 
from SP-sepharose and hydroxylapatite, respectively; lane 5 ffi molecu- 
lar mass markers (sizes given in kilodaltons). (B) Zymogram analysis 
of overexpressed and purified Sit35. Lane 1 = total protein (2.5/~g) 
after induction; lane 2 = 1.25pg purified S1t35; lane 3 = 1.25#g purified 
Sit70 serving as a control. Cleared zones indicate peptidoglycan hydrt, I-
ysis activity. 
hypothesis, and the issue of whether the clipping of the linker 
region is a purification artifact or has physiological relevance, 
remains to be investigated. 
Downstream of the mitB gene a possible open reading frame 
of unknown function was identified and database searching 
using the BLAST algorithm [20] showed that this open reading 
frame is significantly homologous to an open reading frame, 
ydeJ, downstream ofthe raarB locus [21] (data not shown). This 
homology sheds no light on the possible function of the protein 
encoded by the small open reading frame, as the function of 
ydeJ is not known either. 
Although the described homology between the N-terminal 
sequence of S1t35 and a stretch of sequence in Sit70 suggested 
a high degree of sequence conservation between these proteins 
[8], the overall homology between the C-terminal part of Sit70 
and S1t35 turns out to be less convincing, and neither does the 
sequence of S1t35 show significant homology to the proposed 
transglycosylase fingerprint [22]. Based on the fact that the 
catalytic mechanism of Sit70 and proteins that are structurally 
as well as functionally related to Sit70 involves a glutamic acid 
residue, we attempted to identify possible candidates for this 
residue in S1t35. It appeared that introduction of a large gap 
in the primary sequence of Sit70, thereby aligning the catalytic 
glutamic acid of Sit70 with Glu-206 of Sit35, results in a reason- 
ably good alignment in the region comprising two of the three 
conserved boxes that were identified on basis of the structure 
of Sit70 and are indicative for the presence of a lysozyme fold 
(Fig. 2) [23]. The validity of this alignment is currently being 
investigated by mutagenesis of the proposed catalytically im- 
portant Glu-206. The degree of conservation of the conserved 
boxes is, however, less in Sit35 than in a newly identified family 
of putative transglycosylases involved in a variety of transport 
processes (A. Dijkstra, unpublished) which suggest amore dis- 
tant evolutionary relationship. 
For crystallographic purposes, we set out to overexpress the 
protein in its soluble, stable form lacking the proteolysis-sensi- 
tive putative linker region. A very high degree of overproduc- 
tion of soluble protein could be achieved using the T-7 pro- 
moter system [13] (Fig. 3, panel A). The protein was shown to 
be overproduced in an active form, as judged by its ability to 
break down polymeric peptidoglycan both in solution and after 
renaturation from SDS in a zymogram analysis (Fig. 3, panel 
B). The specific production of 1,6-anhydro-muropeptides by 
the overproduced protein could be demonstrated bymeans of 
HPLC (data not shown). 
The high isoelectric point of S1t35 allowed selective binding 
to a strong cation exchanger, esulting in a very efficient puri- 
fication of S1t35 from the soluble fraction of a lysate, as is 
shown in Fig. 3, lane 3. An additional purification step involv- 
ing hydroxylapatite was applied to get rid of minor contaminat- 
ing proteins. This two-step purification scheme was used to 
purify 100 mg amounts of S1t35 for future crystallographic 
studies. 
It will be very interesting to see to what extent he structure 
of S1t35 resembles that of Sit70. The above-mentioned lack of 
high overall sequence homology does not exclude the possibil- 
ity of a structural similarity, as has been shown to be the case 
for Sit70 and the G-type lysozymes [23]. If it indeed turns out 
that Sit35 also contains a lysozyme.like domain, the question 
remains as to the function of the N-terminal-half o the protein. 
Furthermore, obtaining structure-function i formation on 
Sit35 will help to elucidate the catalytic mechanism of the whole 
class of enzymes, as the precise mechanism of the transglyco- 
sylases and even that of the lysozymes i still a matter of debate 
[24], even though the latter mechanism is considered to be 
text-book nowledge. 
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